News

Institutional news
<p>Picture of a colon tumour (Author: Eduard Batlle, IRB).</p>
19 Jan 2017

The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.

The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.

Research will take place during the academic years 2017 and 2018.

 

Scientific news
<p>Staining of mouse liver sections showing steatosis of the liver (fatty liver), with accumulation of fat, lipid droplets (in red), within cells. Cell nuclei stain blue (C. Maíllo, IRB Barcelona).</p>
17 Jan 2017

It is a disease of the liver caused by excessive fat deposits in liver cells.

It is now the most prevalent chronic liver disease in industrialised countries and is a major public health concern because it leads to serious liver conditions.

 

Institutional news
<p>Participants of the “Crazy About Biomedicine”  2017 course.</p>
16 Jan 2017

IRB Barcelona organises a new year-long workshop in the life sciences within the series “Crazy About Science”, run by the Fundació Catalunya – La Pedrera.

“Crazy About Biomedicine” seeks to satisfy students’ interest in science and give them the chance to get a taste of what doing science in a top-class centre is like.

Scientific news
<p>Examples of computationally designed proteins made of curved beta-sheets and helices forming cavities with different sizes and shapes (E.Marcos, IRB Barcelona-UW)</p>
13 Jan 2017

The international team achieved it by discovering the rules behind a type of protein structures that are essential for the interaction between proteins and small molecules

IRB Barcelona researcher, Enrique Marcos, is the first author of the study published today in Science

Scientific news
<p>Ectopic wings upon ectopic activation of JAK/STAT (Carles Recasens-Alvarez and Ana Ferreira, IRB Barcelona)</p>
9 Jan 2017

Researchers at IRB Barcelona identify a fundamental role of the JAK/STAT signalling pathway in the development and growth regulation of limbs in Drosophila.

Published in Nature Communications, the study paves the way to research into the function of this pathway in vertebrate development and its possible involvement in human congenital diseases.

Institutional news
<p>Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)</p>
28 Dec 2016

The VI National 'Doctores Diz Pintado' Cancer Research Prize acknowledges his work and scientific career.

Scientific news
<p>Despite the expanding repertoire of new anti-cancer agents, treatment failure remains a major challenge in the management of most advanced solid tumours, including breast cancer.</p>
20 Dec 2016

A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.

In spite of the many drugs available to treat breast cancer, resistance continues to be a problem.

Institutional news
<p>Patrick Aloy, ICREA Research Professor &amp; ERC Consolidator Grant.</p>
20 Dec 2016

The “Meet Our Scientists” video “Networks of life” explains his work and reveals the personal side of this scientist.

Scientific news
<p>Iproteos is currently performing the regulatory preclinical phase of its drug candidate for CIAS treatment.</p>
19 Dec 2016

Compound IPR19, a drug to stop the progression and reverse the cognitive deficits associated with schizophrenia.

Scientific news
<p>Group leader Salvador Aznar Benitah and first author Gloria Pascual in the Stem Cells and Cancer lab at the IRB Barcelona (M. Minocri, IRB Barcelona)</p>
7 Dec 2016

A study at IRB Barcelona has identified the cells responsible for initiating and promoting metastasis in several types of human tumours.

Their results show that the protein CD36, which absorbs fat from the cell membrane, is an essential factor that determines whether tumour cells become metastatic.

In the absence of CD36, the human tumours analysed did not develop metastasis. In addition, the inhibition of this protein also dramatically reduced the size of existing metastases.

Mice given a high-fat diet developed the most aggressive metastases. The study reports that the metastatic process is enhanced by fat intake.

IRB Barcelona will co-develop antibodies against CD36 with the potential to treat patients.